Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis (Q35798426)

10 August 2017

Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis (English)

1 reference

10 August 2017

0 references

1 reference

Sibel Ada

1

1 reference

10 August 2017

Sibel Ersan

2

1 reference

10 August 2017

Aykut Sifil

3

1 reference

10 August 2017

Mehtat Unlu

4

1 reference

10 August 2017

Efsun Kolatan

5

1 reference

10 August 2017

Mehmet Sert

6

1 reference

10 August 2017

Sulen Sarioglu

7

1 reference

10 August 2017

Osman Yilmaz

8

1 reference

10 August 2017

Taner Camsari

9

1 reference

10 August 2017

3 October 2015

1 reference

International Urology and Nephrology

10 August 2017

1 reference

10 August 2017

47

1 reference

10 August 2017

2047-2051

1 reference

10 August 2017

12

1 reference

Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis

10 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Peritoneal solute transport and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Platelet-derived growth factor receptor-β expression in human peritoneum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Encapsulating peritoneal sclerosis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Quantitative digital histochemistry with methenamine silver staining in renal allograft biopsies excluding pure chronic allograft nephropathy cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Angiogenesis in peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-015-1116-8

Neoangiogenesis in the peritoneal membrane

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Intra-abdominal administration of bevacizumab diminishes intra-peritoneal adhesions

1 reference

12 December 2020

Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.

1 reference

12 December 2020

Successful surgical management of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study

1 reference

12 December 2020

Pathophysiology of peritoneal membrane failure

1 reference

12 December 2020

Morphologic changes in the peritoneal membrane of patients with renal disease

1 reference

12 December 2020

Clinical experience with tamoxifen in peritoneal fibrosing syndromes

1 reference

12 December 2020

Fibrogenic growth factors in encapsulating peritoneal sclerosis

1 reference

12 December 2020

Morphology of the peritoneum: effect of peritoneal dialysis

1 reference

12 December 2020

First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis.

1 reference

12 December 2020

10.1007/S11255-015-1116-8

Identifiers

DOI

1 reference

10 August 2017

1 reference